Ivo Staijen
Head-Equity Investments bei HBM Partners AG (Investment Management)
Profil
Dr. Ivo Staijen is a Head Public Equity & Portfolio Manager at HBM Partners AG.
He has over 15 years of experience in the pharma industry and investment analysis and portfolio management.
He was previously a Senior Biotechnology Analyst at Bank Sarasin and Department Head at MDS Pharma Services.
He holds a Ph.D.
in biotechnology from ETH Zurich and an M.Sc.
in chemistry from the University of Groningen.
Aktive Positionen von Ivo Staijen
| Unternehmen | Position | Beginn |
|---|---|---|
HBM Partners AG (Investment Management)
 HBM Partners AG (Investment Management) Investment ManagersFinance HBM Partners AG (Investment Management) (HBM-IM) is the asset management division of HBM Partners AG. The firm is headquartered in Zug and was founded in 2001. HBM-IM provides investment advisory services to private companies. They manage the fund HBM Healthcare Investments. | Head-Equity Investments | 01.04.2003 |
Ehemalige bekannte Positionen von Ivo Staijen
| Unternehmen | Position | Ende |
|---|---|---|
Surface Logix LLC
 Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 03.10.2012 |
| Bank Sarasin & Cie AG (Broker) | Analyst-Equity | 06.02.2003 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Health Technology |
| Bank Sarasin & Cie AG (Broker) | Finance |
HBM Partners AG (Investment Management)
HBM Partners AG (Investment Management) Investment ManagersFinance HBM Partners AG (Investment Management) (HBM-IM) is the asset management division of HBM Partners AG. The firm is headquartered in Zug and was founded in 2001. HBM-IM provides investment advisory services to private companies. They manage the fund HBM Healthcare Investments. | Finance |
